Tru-Scint AD: Received clearance to conduct a Phase II trial

Biomira Inc. (BIOMF), Edmonton, Alberta Product: Tru-Scint AD monoclonal antibody coupled to technetium-99m Indication: Newly diagnosed, primary breast cancer Status: Received Canadian clearance to co...